APA (7th ed.) Citation

Lin, S., He, L., Xie, L., Wang, Y., Lin, Y., Cao, Y., . . . Huang, G. (2021). Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: Study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial. Trials, 22(1), 1. https://doi.org/10.1186/s13063-021-05807-3

Chicago Style (17th ed.) Citation

Lin, Si-Yuan, Lan He, Li-Ping Xie, Yin Wang, Yi-Xiang Lin, Yin-Yin Cao, Wei-Li Yan, Fang Liu, and Guo-Ying Huang. "Effects of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesions in Patients with Kawasaki Disease: Study Protocol for a Phase III Multicenter, Open-label, Blinded-endpoints Randomized Controlled Trial." Trials 22, no. 1 (2021): 1. https://doi.org/10.1186/s13063-021-05807-3.

MLA (9th ed.) Citation

Lin, Si-Yuan, et al. "Effects of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesions in Patients with Kawasaki Disease: Study Protocol for a Phase III Multicenter, Open-label, Blinded-endpoints Randomized Controlled Trial." Trials, vol. 22, no. 1, 2021, p. 1, https://doi.org/10.1186/s13063-021-05807-3.